Advanced search
1 file | 5.15 MB Add to list

Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study

(2022) CANCERS. 14(4).
Author
Organization
Abstract
Simple Summary Although the SARS-CoV-2 pandemic is likely to have created or aggravated mental health symptoms in cancer patients, high-quality longitudinal data on this topic are scarce. The aim of our prospective survey study was to assess cancer patient-reported mental health and quality of life (QOL) at four time points during the first two waves of the pandemic. We found that an important proportion of the 355 participants reported symptoms of COVID-19 peritraumatic distress (34.2% to 39.6%), depression (27.6% to 33.5%), anxiety (24.9% to 32.7%), and stress (11.4% to 15.7%) at any time point during the study period. However, we did not find clinically meaningful mental health and QOL changes during the study period. Additionally, we found no factors associated with better or worse mental health or QOL. In conclusion, the cancer patients who participated in this study showed considerable resilience against mental health and QOL deterioration during the pandemic. Purpose: This longitudinal survey study aimed to investigate the self-reported outcome measures of COVID-19 peritraumatic distress, depression, anxiety, stress, quality of life (QOL), and their associated factors in a cohort of cancer patients treated at a tertiary care hospital during the SARS-CoV-2 pandemic. Methods: Surveys were administered at four time points between 1 April 2020 and 18 September 2020. The surveys included the CPDI, DASS-21, and WHOQOL-BREF questionnaires. Results: Survey response rates were high (61.0% to 79.1%). Among the 355 participants, 71.3% were female, and the median age was 62.2 years (IQR, 53.9 to 69.1). The majority (78.6%) were treated with palliative intention. An important proportion of the participants reported symptoms of COVID-19 peritraumatic distress (34.2% to 39.6%), depression (27.6% to 33.5%), anxiety (24.9% to 32.7%), and stress (11.4% to 15.7%) at any time point during the study period. We did not find clinically meaningful mental health and QOL differences during the study period, with remarkably little change in between the pandemic's first and second wave. We found no consistent correlates of mental health or QOL scores, including cancer type, therapy intention, and sociodemographic information. Conclusion: This cohort of cancer patients showed considerable resilience against mental health and QOL deterioration during the SARS-CoV-2 pandemic.
Keywords
Cancer Research, Oncology, mental health, quality of life, cancer, SARS-CoV-2, coronavirus 2019, pandemic, IMPACT, UK

Downloads

  • cancers-14-01093-v2.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 5.15 MB

Citation

Please use this url to cite or link to this publication:

MLA
De Jaeghere, Emiel, et al. “Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic : Results from the Longitudinal ONCOVID Survey Study.” CANCERS, vol. 14, no. 4, 2022, doi:10.3390/cancers14041093.
APA
De Jaeghere, E., Kanervo, H., Colman, R., Schrauwen, W., West, P., Vandemaele, N., … Denys, H. (2022). Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study. CANCERS, 14(4). https://doi.org/10.3390/cancers14041093
Chicago author-date
De Jaeghere, Emiel, Heini Kanervo, Roos Colman, Wim Schrauwen, Paulien West, Nele Vandemaele, Aglaja De Pauw, et al. 2022. “Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic : Results from the Longitudinal ONCOVID Survey Study.” CANCERS 14 (4). https://doi.org/10.3390/cancers14041093.
Chicago author-date (all authors)
De Jaeghere, Emiel, Heini Kanervo, Roos Colman, Wim Schrauwen, Paulien West, Nele Vandemaele, Aglaja De Pauw, Celine Jacobs, Ingeborg Hilderson, Michael Saerens, Nora Sundahl, Katrien Vandecasteele, Eline Naert, Lore Lapeire, Vibeke Kruse, Sylvie Rottey, Gilbert Lemmens, and Hannelore Denys. 2022. “Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic : Results from the Longitudinal ONCOVID Survey Study.” CANCERS 14 (4). doi:10.3390/cancers14041093.
Vancouver
1.
De Jaeghere E, Kanervo H, Colman R, Schrauwen W, West P, Vandemaele N, et al. Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study. CANCERS. 2022;14(4).
IEEE
[1]
E. De Jaeghere et al., “Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study,” CANCERS, vol. 14, no. 4, 2022.
@article{8742480,
  abstract     = {{Simple Summary Although the SARS-CoV-2 pandemic is likely to have created or aggravated mental health symptoms in cancer patients, high-quality longitudinal data on this topic are scarce. The aim of our prospective survey study was to assess cancer patient-reported mental health and quality of life (QOL) at four time points during the first two waves of the pandemic. We found that an important proportion of the 355 participants reported symptoms of COVID-19 peritraumatic distress (34.2% to 39.6%), depression (27.6% to 33.5%), anxiety (24.9% to 32.7%), and stress (11.4% to 15.7%) at any time point during the study period. However, we did not find clinically meaningful mental health and QOL changes during the study period. Additionally, we found no factors associated with better or worse mental health or QOL. In conclusion, the cancer patients who participated in this study showed considerable resilience against mental health and QOL deterioration during the pandemic. Purpose: This longitudinal survey study aimed to investigate the self-reported outcome measures of COVID-19 peritraumatic distress, depression, anxiety, stress, quality of life (QOL), and their associated factors in a cohort of cancer patients treated at a tertiary care hospital during the SARS-CoV-2 pandemic. Methods: Surveys were administered at four time points between 1 April 2020 and 18 September 2020. The surveys included the CPDI, DASS-21, and WHOQOL-BREF questionnaires. Results: Survey response rates were high (61.0% to 79.1%). Among the 355 participants, 71.3% were female, and the median age was 62.2 years (IQR, 53.9 to 69.1). The majority (78.6%) were treated with palliative intention. An important proportion of the participants reported symptoms of COVID-19 peritraumatic distress (34.2% to 39.6%), depression (27.6% to 33.5%), anxiety (24.9% to 32.7%), and stress (11.4% to 15.7%) at any time point during the study period. We did not find clinically meaningful mental health and QOL differences during the study period, with remarkably little change in between the pandemic's first and second wave. We found no consistent correlates of mental health or QOL scores, including cancer type, therapy intention, and sociodemographic information. Conclusion: This cohort of cancer patients showed considerable resilience against mental health and QOL deterioration during the SARS-CoV-2 pandemic.}},
  articleno    = {{1093}},
  author       = {{De Jaeghere, Emiel and Kanervo, Heini and Colman, Roos and Schrauwen, Wim and West, Paulien and Vandemaele, Nele and De Pauw, Aglaja and Jacobs, Celine and Hilderson, Ingeborg and Saerens, Michael and Sundahl, Nora and Vandecasteele, Katrien and Naert, Eline and Lapeire, Lore and Kruse, Vibeke and Rottey, Sylvie and Lemmens, Gilbert and Denys, Hannelore}},
  issn         = {{2072-6694}},
  journal      = {{CANCERS}},
  keywords     = {{Cancer Research,Oncology,mental health,quality of life,cancer,SARS-CoV-2,coronavirus 2019,pandemic,IMPACT,UK}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{19}},
  title        = {{Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study}},
  url          = {{http://dx.doi.org/10.3390/cancers14041093}},
  volume       = {{14}},
  year         = {{2022}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: